Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 09 Nov 2023

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer

in Cancer Immunity and Immunotherapy

Rui Zhou
Fan Tong
Yongchang Zhang
Ruigang Zhang
Yawen Bin
Sheng Zhang
Nong Yang
Xiaorong Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1231094

2,351 views

Case Report

Published on 08 Nov 2023

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab

in Cancer Immunity and Immunotherapy

Wei Cen Wang
Beatrice Preti
Nancy Read
Paul Gibson
Keith Kwan
Eric Winquist

Frontiers in Oncology

doi 10.3389/fonc.2023.1249453

1,909 views
2 citations

Editorial

Published on 08 Nov 2023

Editorial: Immune-related adverse events for patients with lung cancer-volume II

in Cancer Immunity and Immunotherapy

Yusha Wang
Xia Wang
Cheng Zhan
Benjamin Frey
Udo S. Gaipl
Hubing Shi
Xuelei Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1282394

1,188 views

Review

Published on 03 Nov 2023

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment

in Cancer Immunity and Immunotherapy

Son Hai Vu
Ha Hong Pham
Thao Thi Phuong Pham
Thanh Thien Le
Manh-Cuong Vo
Sung-Hoon Jung
Je-Jung Lee
Xuan-Hung Nguyen

Frontiers in Oncology

doi 10.3389/fonc.2023.1275076

5,708 views
4 citations

Editorial

Published on 01 Nov 2023

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy

in Cancer Immunity and Immunotherapy

Xiaoran Yin
Yan Feng
Bowen Zhang
Xueyan Mao
Siying Chen
Yuyan Wang
Sidney W. Fu

Frontiers in Oncology

doi 10.3389/fonc.2023.1301340

1,260 views
1 citation

Original Research

Published on 01 Nov 2023

Genomic profiling and immune landscape of olfactory neuroblastoma in China

in Cancer Immunity and Immunotherapy

Yunyun Yang
Zhiyi Wan
Enli Zhang
Yingshi Piao

Frontiers in Oncology

doi 10.3389/fonc.2023.1226494

2,636 views
5 citations

Original Research

Published on 30 Oct 2023

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma

in Cancer Immunity and Immunotherapy

Xu Sun
Zhanpeng Liu
Qian Yu
Yinwei Chen
Yunwen Sun
Qingyi Zhu
Jian Yang
Rongjiang Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1207551

2,721 views
2 citations

Original Research

Published on 27 Oct 2023

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets

in Cancer Immunity and Immunotherapy

Yang Lv
Qiang Li
Lu Yin
Shaohua He
Chao Qin
Zhongwen Lu
Hongqi Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1271864

3,152 views
1 citation

Original Research

Published on 27 Oct 2023

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers

in Cancer Immunity and Immunotherapy

Chuang Yang
Patrick Sven Plum
Ines Gockel
René Thieme

Frontiers in Oncology

doi 10.3389/fonc.2023.1186101

2,602 views
4 citations

Systematic Review

Published on 26 Oct 2023

Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Tibera K. Rugambwa
Omar Abdihamid
Xiangyang Zhang
Yinghui Peng
Changjing Cai
Hong Shen
Shan Zeng
Wei Qiu

Frontiers in Oncology

doi 10.3389/fonc.2023.1181248

3,227 views
9 citations

Original Research

Published on 26 Oct 2023

Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Qihang Wu
Yuxiang Sun
Xiangcheng Qin
Maomao Li
Shuaishuai Huang
Xue Wang
Guobin Weng

Frontiers in Oncology

doi 10.3389/fonc.2023.1211103

1,492 views
2 citations

Original Research

Published on 24 Oct 2023

Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer

in Cancer Immunity and Immunotherapy

Xu Chen
Qihang Yuan
Hewen Guan
Xueying Shi
Jiaao Sun
Zhiqiang Wu
Jie Ren
Shilin Xia
Dong Shang

Frontiers in Oncology

doi 10.3389/fonc.2023.1227606

3,429 views
3 citations

Mini Review

Published on 24 Oct 2023

Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications

in Cancer Immunity and Immunotherapy

Vianey Rodriguez-Lara
Giovanny Soca-Chafre
Maria Rosa Avila-Costa
Juan Jose Juarez-Vignon Whaley
Jeronimo Rafael Rodriguez-Cid
José Luis Ordoñez-Librado
Emma Rodriguez-Maldonado
Nallely A. Heredia-Jara

Frontiers in Oncology

doi 10.3389/fonc.2023.1210297

5,041 views
7 citations

Editorial

Published on 23 Oct 2023

Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers

in Cancer Immunity and Immunotherapy

Yawei Qian
Wenyu Jia
Hongda Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1301416

1,057 views

Brief Research Report

Published on 23 Oct 2023

Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports

in Cancer Immunity and Immunotherapy

Pasquale Esposito
Annarita Bottini
Elvina Lecini
Francesca Cappadona
Michela Piaggio
Lucia Macciò
Carlo Genova
Francesca Viazzi

Frontiers in Oncology

doi 10.3389/fonc.2023.1221135

2,551 views
2 citations

Original Research

Published on 20 Oct 2023

Importance of metabolic and immune profile as a prognostic indicator in patients with diabetic clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Xiangyu Cheng
Yanlian Hou

Frontiers in Oncology

doi 10.3389/fonc.2023.1280618

2,272 views
2 citations